https://pubmed.ncbi.nlm.nih.gov/38549671/?dopt=Abstract
CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and...
Inhibition of p38 mitogen-activated protein kinase (MAPKs) is a potential therapeutic approach for the treatment of acute and chronic pulmonary inflammatory...